• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Izafe Group

0.34 SEK+1.51 %31.7. klo 18.29
Less than 1K followers

IZAFE B

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+1.51 %
-11.08 %
-10.85 %
-24.61 %
-29.79 %
+12.33 %
+68.50 %
-82.84 %
-90.29 %

iZafe Group is a Life Science company focused on the development and marketing of digital medical solutions for home medication management. The company offers, among other things, a medication robot, SaaS solutions and a connected dosing bag. The products aim to reduce the risk of medication errors. Customers include individuals, pharmaceutical companies and public and private healthcare providers globally. iZafe Group is headquartered in Stockholm.

Read more
Market cap
148.61M SEK
Turnover
167.21K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
EPS and dividend
Financial calendar
1.9.
2026

Interim report Q2'26

3.11.
2026

Interim report Q3'26

16.2.
2027

Annual report '26

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release31.07.2026 klo 21.30

iZafe Group AB has carried out a directed set-off issue of B shares as partial payment for the acquisition of its Dutch subsidiary

Izafe Group
Regulatory press release10.07.2026 klo 15.00

iZafe Group AB carries out the first partial payment for the acquisition of its Dutch subsidiary through a set-off issue of B shares

Izafe Group
Press release07.07.2026 klo 09.45

June monthly letter – strong pipeline and preparations for an intensive autumn

Izafe Group

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Press release26.06.2026 klo 15.30

iZafe Group’s CEO transfers shares privately to enable participation in LTIP 2026:I

Izafe Group
Press release08.06.2026 klo 13.00

May monthly letter: continued scaling and increased utilisation

Izafe Group
Press release08.05.2026 klo 14.30

Monthly Letter April – Increased Activity and Growing Implementations

Izafe Group
Regulatory press release28.04.2026 klo 09.30

iZafe Group Q1 Interim Report, January-March 2026

Izafe Group
Press release23.04.2026 klo 09.30

Dosell awarded contract with Västervik Municipality regarding medication dispensing devices

Izafe Group
Press release13.04.2026 klo 12.00

iZafe Group Achieves ISO/IEC 27001 Certification and Strengthens Its Position for International Expansion

Izafe Group
Press release10.04.2026 klo 09.30

Monthly Update March – ADDA in effect and preparations for the next growth phase

Izafe Group
Press release07.04.2026 klo 09.30

Dosell AB awarded contract with Region Jönköping County and its municipalities

Izafe Group
Press release01.04.2026 klo 10.00

Dosell AB Granted European Patent in Data-Driven Medication Management

Izafe Group
Press release12.03.2026 klo 17.00

Dosell AB signs framework agreement with Adda following the end of the appeal period

Izafe Group
Regulatory press release12.03.2026 klo 16.00

Communiqué from the Extraordinary General Meeting of iZafe Group AB

Izafe Group
Press release09.03.2026 klo 10.00

Monthly Letter February – ADDA, Growth Capital and Preparations for Scaling

Izafe Group
Press release26.02.2026 klo 17.10

Dosell Awarded Framework Agreement in Sweden’s First National Procurement of Medication Dispensing Systems

Izafe Group
Regulatory press release19.02.2026 klo 09.40

iZafe Group AB has resolved on a directed share issue of class B shares of approximately SEK 19.8 million in order to accelerate the pace of sales and installations.

Izafe Group
Regulatory press release16.02.2026 klo 09.30

iZafe Group’s Quarterly Report Q4, October–December 2025

Izafe Group
Press release10.02.2026 klo 10.00

Monthly Update January – Broad Momentum and the Launch of a New Platform

Izafe Group
Press release21.01.2026 klo 10.00

iZafe Group launches modular Display and remote care system – one Dosell for all users

Izafe Group